Vaccinopolis: University of Antwerp opens centre for vaccine studies
A new centre dedicated to vaccine studies and infectious disease research opened on Friday at the University of Antwerp’s Drie Eiken campus.
Called Vaccinopolis, the ultramodern centre aims to accelerate the development of vaccines and therapeutics by offering the possibility to observe participants after pathogen exposure for longer periods of time.
A multidisciplinary team with over 35 years of experience aims to contribute to the evaluation of candidate vaccines and commercialised vaccines against epidemic and endemic pathogens, the need for which was never more greatly highlighted than during the Covid-19 pandemic.
“Vaccinopolis offers a unique flexibility to perform just about any kind of vaccine research and provides the possibility to perform both ambulatory and contained studies at the same time,” the university said in a statement.
“We are convinced that this unit can greatly accelerate the development and evaluation of vaccine candidates.”
Vaccinopolis has been built according to the strictest safety standards to guarantee the safety of the participants, the staff and the environment at all times, the university says.
Their team has been working in vaccine studies and infectious disease research since 1984, conducting over 500 national and international clinical vaccine studies with vaccines against various pathogens, including Hepatitis B virus, polio, influenza, Dengue, HPV and Covid-19.
Now, in a unique 6000-square-metre clinical infrastructure strategically located in Antwerp, they’ll be able to do so using 30 individual containment rooms, a department for outpatient vaccine studies and fully equipped labs.
© BELGA PHOTO JONAS ROOSENS